Questo è quello che abbiamo trovato per te
Complessivamente in tutta Italia sono 544 i Comuni con «l’indice di criticità potenziale» più alto relativo all’assistenza sanitaria agli over 80
Ad un anno e mezzo dalla loro messa a regime questi maxi ambulatori restano per molti cittadini ancora un oggetto misterioso
‘Regioni individuino i laboratori per l’esecuzione dell’esame’
Introduction
Global disparities in HIV prevalence among transgender women are well documented. However, current epidemiological literature on HIV disparities demonstrates gaps in research that include the diversity within transgender populations—for example, transgender men and non-binary trans people across global regions. This systematic review and meta-analysis protocol aims to summarise global HIV inequities among all transgender and non-binary (trans) populations. The objectives of this review are to estimate pooled HIV prevalence and prevention outcomes (pre-exposure prophylaxis and antiretroviral therapy) and differences by gender identity, global regions and self-report versus lab-confirmed findings among trans adults worldwide.
Methods and analysis
We will conduct a systematic review of all studies on HIV outcomes among trans youth and adults (aged 15+ years) published between 2000 and 2024, following the Preferred Reporting Items for Systematic Review and Meta-Analysis Prereporting guidelines. We will use Covidence software for the title and abstract screening, full-text review and data abstraction processes. We will summarise the study’s descriptive statistics and conduct meta-analyses of extracted data points to calculate and synthesise pooled findings and effect size. Specifically, we will use the Mantel–Haenszel method with random effects to model our meta-analyses and the DerSimonian and Laird Q test for heterogeneity testing. We will conduct a narrative synthesis on the areas of research that have been conducted to improve HIV prevention and treatment among trans populations and summarise their findings. Subgroup analyses by gender identity, global regions and self-report versus lab-confirmed findings will be conducted.
Ethics and dissemination
Ethics approval is not applicable for this review since we will not be collecting primary data. The results will be disseminated through peer-reviewed publications and conference presentations.
PROSPERO registration number
The protocol is registered in the International Prospective Register of Systematic Reviews database (PROSPERO ID: CRD42022357285).
‘Impossibile aggiornare programmi informatici in pochi giorni’
New England Journal of Medicine, Volume 392, Issue 1, Page 81-82, January 2, 2025.
Il Tribunale amministrativo del Lazio ha deciso di sospendere il decreto che oltre ad aggiungere i nuovi Lea aggiorna anche 1.113 tariffe
Il ricorso è stato presentato da centinaia di strutture accreditate
A fine anno l’aggiornamento dei tariffari, dalla Procreazione medicalmente assistita alle protesi tech. ‘Autismo dimenticato’
A fine anno l’aggiornamento dei tariffari, dalla Procreazione medicalmente assistita alle protesi tech. ‘Autismo dimenticato’
Dopo il via libera della Stato Regioni alle linee guida la sua messa a regime è prevista entro il prossimo febbraio
Most transgender youth who received medical interventions including puberty blockers or hormones expressed satisfaction with their treatment, according to a study published in JAMA Pediatrics.
Emilia più attrattiva. Cittadinanzattiva, nodo malattie croniche
Emilia più attrattiva. Cittadinanzattiva, nodo malattie croniche
In alcuni casi di recidiva si possono colpire mutazioni geniche
Stabilizza vista e può ridurre necessità iniezioni intravitreali
